CYNTHIA PARADISE: Open Payments
NPI 1861490708 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,397 in 124 payments from 19 companies in 2025. Trend: 2023 $1,993 · 2024 $1,297 · 2025 $2,397
Food & beverage: $2,339Education: $58
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $531 |
| LEO Pharma Inc. | 12 | $339 |
| Janssen Biotech, Inc. | 19 | $228 |
| Regeneron Healthcare Solutions, Inc. | 8 | $226 |
| Galderma Laboratories, L.P. | 11 | $226 |
| Novartis Pharmaceuticals Corporation | 8 | $169 |
| GENZYME CORPORATION | 4 | $100 |
| E.R. Squibb & Sons, L.L.C. | 4 | $90 |
| Incyte Corporation | 4 | $90 |
| UCB, Inc. | 4 | $88 |
Products named: SKYRIZI, DUPIXENT, ADBRY, TREMFYA, RINVOQ, NEMLUVIO, COSENTYX, Sotyktu.
Industry payments across MA — which companies pay providers there.
